News & media

  • COMPANY ANNOUNCEMENT

    Zealand Pharma increases its share capital as a result of the exercise of employee warrants

  • PRESS RELEASE

    Zealand Pharma submits Marketing Authorization Application to the European Medicines Agency for glepaglutide in short bowel syndrome

  • COMPANY ANNOUNCEMENT

    Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

  • PRESS RELEASE

    Zealand Pharma continues to strengthen strategic leadership of innovation in obesity and related conditions with appointment of Steven Johnson as Chief Development Officer

  • PRESS RELEASE

    Zealand Pharma to participate in upcoming healthcare investor conferences in May and June 2025

  • COMPANY ANNOUNCEMENT

    Zealand Pharma announces closing of collaboration and license agreement with Roche

  • COMPANY ANNOUNCEMENT

    Zealand Pharma Announces Financial Results for the First Three Months of 2025

  • PRESS RELEASE

    Zealand Pharma conference call on May 8 at 2pm CET (8am ET) to present first quarter 2025 financial results

  • PRESS RELEASE

    Zealand Pharma announces first participant enrolled in Phase 2b ZUPREME-2 trial of petrelintide in people with overweight or obesity and type 2 diabetes

  • PRESS RELEASE

    Zealand Pharma appoints Utpal Singh as Chief Scientific Officer to drive next-generation peptide therapeutics discovery

  • COMPANY ANNOUNCEMENT

    Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

  • COMPANY ANNOUNCEMENT

    Zealand Pharma launches long-term incentive programs for Zealand Pharma’s Board of Directors, Corporate Management and employees for 2025

Corporate management

  • Adam ALR0640

    Adam Steensberg - President and Chief Executive Officer

  • Zealand Pharma 0285 FIN

    Adam Steensberg - President and Chief Executive Officer

  • Adam ALR0631

    Adam Steensberg - President and Chief Executive Officer

  • Henriette ALR0758

    Henriette Wennicke - Executive Vice President and Chief Financial Officer

  • Christina ALR0693 V2

    Christina Sonnenborg Bredal - Executive Vice President and Chief People Officer

  • David ALR1003

    David Kendall - Executive Vice President, Research & Development and Chief Medical Officer

  • Ivan ALR0873

    Ivan Møller - Executive Vice President and Chief Operating Officer

  • Utpal Singh 1

    Utpal Singh - Executive Vice President and Chief Scientific Officer

  • Utpal Singh 2

    Utpal Singh - Executive Vice President and Chief Scientific Officer

  • Steven Johnson

    Steven Johnson - Executive Vice President, Chief Development Officer

  • Eric Cox ALR8394

    Eric Cox - Executive Vice President, Chief Commercial Officer

Research and development

Sustainability

Logos and icons

Zealand Pharma 1503

Stay up-to-date with the latest news from Zealand

Sign-up to receive press releases and company announcements directly to your inbox

Subscribe to news

Investor and Media contacts